ID   CHLA-215
AC   CVCL_AQ36
SY   CHLA215
DR   Wikidata; Q54812181
RX   CelloPub=CLPUB00315;
RX   PubMed=27050416;
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 14
ST   D16S539: 12
ST   D18S51: 18,19
ST   D19S433: 13,13.2
ST   D21S11: 29,31
ST   D2S1338: 23
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 7
//
RX   CelloPub=CLPUB00315;
RA   Kalous O., Watanabe J., Murphree A.L., Reynolds C.P.;
RT   "Pre-clinical testing of chemotherapy combinations in retinoblastoma
RT   cell lines using the dimscan cytotoxicity assay.";
RL   Invest. Ophthalmol. Vis. Sci. 44:S4980-S4980(2003).
//
RX   PubMed=27050416; DOI=10.1371/journal.pone.0153011; PMCID=PMC4822873;
RA   Ferrario A., Luna M.C., Rucker N., Wong S., Lederman A., Kim J.,
RA   Gomer C.J.;
RT   "Targeting survivin enhances chemosensitivity in retinoblastoma cells
RT   and orthotopic tumors.";
RL   PLoS ONE 11:e0153011.1-e0153011.16(2016).
//